News

Reveal Biosciences and QuantumCyte Partner to Offer a New Generation of Multi-omic Data

Precision medicine has come a long way towards benefiting patient outcomes and enhancing research tools. In recent years, the integration of multi-scale omics from genomic, proteomic, and transcriptomic foundations has impacted how biological pathways and disease progression are studied. The industry has rapidly progressed due to both improved, ultra-sensitive technologies and increased awareness across expert …

Reveal Biosciences and QuantumCyte Partner to Offer a New Generation of Multi-omic Data Read More »

AI: Advancing Patient Access and Outcomes

Biocom’s 4th Annual Big Data Summit, held October 29, 2019 in La Jolla, CA, brought together thought leaders in artificial intelligence (AI), computational drug discovery, and blockchain technology. Throughout the day a recurring theme emerged: machine learning improves the affordability, speed, quality and utility of complex applications. Technology advancements over the last 5 years have …

AI: Advancing Patient Access and Outcomes Read More »

imageDx: NASH – A New Generation of Quantitative NASH Data

Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general population as being affected (1). NAFLD, while mainly asymptomatic, can progress to non-alcoholic steatohepatitis (NASH) in a portion of individuals. NASH is characterized by multiple pathologic …

imageDx: NASH – A New Generation of Quantitative NASH Data Read More »

Spheroids: Research in 3D

What Are Spheroids? A spheroid is a small, spherical cluster of cells that acts as a 3D cell culture. The term “organoid” is also used interchangeably with “spheroid”, although the former specifically refers to a 3D cluster of organ-specific cells. Spheroids and organoids can be artificially assembled through different methods, including the use of centrifugal …

Spheroids: Research in 3D Read More »

AACR Highlights: Focus on AI

The 110th Annual Meeting of the American Association for Cancer Research launched on March 30th, 2019 in Atlanta, GA. Over 22,000 delegates attended including scientists, clinicians, and patient advocates from around the globe. A team from Reveal Biosciences was present to highlight our recent advances in the application of artificial intelligence (AI) in pathology for …

AACR Highlights: Focus on AI Read More »

Reveal Biosciences, a Global Pathology AI Leader, Raises Series A Funding Led by Intel Capital

San Diego, CA. (April 2nd, 2019). Reveal Biosciences, Inc., a leader in pathology AI, announces today that it has closed a Series A financing round led by Intel Capital with additional investment from the GNI Group and PP Capital. Reveal is focused on improving global healthcare by creating a new generation of objective, data-powered pathology …

Reveal Biosciences, a Global Pathology AI Leader, Raises Series A Funding Led by Intel Capital Read More »

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice

Reveal Biosciences attended Biocom’s recent CRO seminar on Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice. Pharmatest Services and Taconic Biosciences hosted this informative seminar where they presented on humanized immune system models for immunotherapies and on humanized mouse models of bone metastasis. Paul Volden, Associate Director of External Collaboration and Innovation at Taconic …

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice Read More »

Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston

Reveal Biosciences Founder and CEO, Dr. Claire Weston, was recently featured in the Tech Spotlight interview series. This interview covered topics such as the inception of Reveal Biosciences, the future impact of AI on pathology, and more. You can read the full interview on the Managed Solution website by clicking here. Here’s Claire’s response to …

Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston Read More »